Julie Bertrand
- Modeling and Simulation top 2%
- Statistics and Probability top 5%
- Statistical Methods in Clinical Trials 15
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 5
- HIV/AIDS drug development and treatment 4
- Virology top 10%
- HIV Research and Treatment 4
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment 6
-
- Drug Transport and Resistance Mechanisms 5
-
- Treatment of Major Depression 5
-
- Optimal Experimental Design Methods 5
- Co-authors
- France MentréEmmanuelle CometsJérémie GuedjMarylore ChenelSuzanne ReevesRobert HowardOlivier TerrierRuian Ke
- Journals
- CPT Pharmacometrics & Systems Pharmacology (6 papers)The AAPS Journal (5 papers)Journal of Biopharmaceutical Statistics (3 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Julie Bertrand
43 papers receiving 721 citations
Peers
Comparison fields: 5 of 104
- Modeling and Simulation 108
- Statistics and Probability 132
- Infectious Diseases 272
- Virology 60
- Psychiatry and Mental health 107
Countries citing papers authored by Julie Bertrand
This map shows the geographic impact of Julie Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Bertrand more than expected).
Fields of papers citing papers by Julie Bertrand
This network shows the impact of papers produced by Julie Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Bertrand. The network helps show where Julie Bertrand may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julie Bertrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 37 | |
| 8 | 2023 | 3 | |
| 9 | 2021 | 75 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 10 | |
| 12 | 2020 | 7 | |
| 13 | 2017 | 9 | |
| 14 | 2016 | 17 | |
| 15 | 2015 | 6 | |
| 16 | 2015 | 18 | |
| 17 | 2013 | 12 | |
| 18 | 2012 | 43 | |
| 19 | 2011 | 12 | |
| 20 | 2011 | 25 |
About Julie Bertrand
Julie Bertrand is a scholar working on Statistics and Probability, Virology and Psychiatry and Mental health, having authored 43 papers that have together received 736 indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (15 papers), Schizophrenia research and treatment (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Treatment of Major Depression (5 papers), Optimal Experimental Design Methods (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (4 papers). The work is most often cited by research in Modeling and Simulation (108 citations), Statistics and Probability (132 citations) and Infectious Diseases (272 citations). Julie Bertrand has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include France Mentré, Emmanuelle Comets, Jérémie Guedj, Marylore Chenel, Suzanne Reeves, Robert Howard, Olivier Terrier, Ruian Ke, Alan S. Perelson and Manuel Rosa‐Calatrava. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, The AAPS Journal, Journal of Biopharmaceutical Statistics, British Journal of Clinical Pharmacology and Pharmacogenetics and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.